MRVI
Maravai Lifesciences Holdings Inc
7.20$
-3.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.6% | 30.0% | 45.2% | 22.5% | 23.8% | 21.2% | 17.4% | 15.7% | 17.8% | 16.4% | 15.4% | 20.0% | 26.0% | 42.6% | 62.8% | 54.9% | 47.4% | 59.7% | 52.1% | 56.5% | 66.4% | 83.5% | 83.6% | 86.4% | 75.5% | 48.8% | 59.9% | 65.4% | |
| 50.4% | 70.0% | 54.8% | 77.5% | 76.2% | 78.8% | 82.6% | 84.3% | 82.2% | 83.6% | 84.6% | 80.0% | 74.0% | 57.4% | 37.2% | 45.1% | 52.6% | 40.3% | 47.9% | 43.5% | 33.6% | 16.5% | 16.4% | 13.6% | 24.5% | 51.2% | 40.1% | 34.6% | |
| 2.7% | 7.3% | 3.4% | 2.1% | 2.1% | 1.5% | 0.9% | 1.0% | 4.0% | 1.5% | 1.8% | 2.8% | 2.4% | 5.2% | 6.1% | 6.5% | 6.2% | 7.8% | 7.2% | 6.7% | 8.1% | 10.4% | 10.3% | 23.5% | 7.6% | 5.9% | 7.2% | 10.1% | |
| 43.9% | 31.6% | 34.1% | 23.3% | 95.8% | 15.7% | 11.1% | 12.3% | 11.2% | 13.6% | 8.3% | 16.1% | 18.2% | 48.9% | 51.3% | 58.1% | 51.9% | 63.7% | 55.3% | 59.9% | 73.1% | 84.4% | 81.4% | 85.0% | 63.3% | 44.2% | 62.3% | 61.4% | |
| 46.8% | 1.7% | 37.5% | 25.5% | 44.4% | 17.3% | 12.1% | 8.4% | 16.1% | 15.1% | 10.1% | 18.9% | 20.6% | 54.2% | 54.1% | 68.2% | 62.3% | 69.7% | 60.8% | 302.9% | 101.2% | 121.4% | 156.2% | -263.7% | 38.1% | 47.4% | 69.5% | -11.4% | |
| 3.6% | 68.3% | 17.3% | 52.0% | 31.8% | 61.5% | 70.5% | 75.9% | 66.1% | 68.5% | 74.4% | 61.1% | 53.4% | 3.2% | -16.9% | -23.1% | -9.6% | -29.4% | -13.0% | -259.4% | -67.6% | -104.9% | -139.8% | 277.3% | -13.5% | 3.8% | -29.3% | 46.0% | |
| 21.5% | 14.5% | 15.9% | 8.1% | 9.0% | 5.3% | 3.5% | 3.8% | 1.9% | 1.1% | 1.8% | 1.6% | 5.0% | 15.0% | 10.2% | 17.4% | 20.8% | 16.9% | 16.3% | 20.9% | 20.0% | 14.5% | 14.4% | 16.4% | 13.1% | 8.7% | 9.3% | 11.5% | |
| -17.8% | 54.0% | 1.4% | 44.0% | 15.1% | 60.2% | 67.0% | 73.7% | 63.0% | 68.3% | 72.1% | 59.5% | 46.8% | -5.7% | -19.4% | -30.8% | 885.1% | -34.9% | -23.1% | -269.4% | -82.4% | -112.5% | -156.4% | -108.5% | -126.4% | -9.9% | -42.4% | -65.4% | |
| -2.7% | 7.1% | -1.6% | -0.4% | 0.4% | 9.2% | 5.2% | 9.2% | 7.7% | 8.2% | 7.5% | 7.4% | 4.1% | -4.0% | -2.1% | -8.2% | 1,033.4% | 0.4% | -3.3% | 0.5% | 0.0% | 0.3% | -9.0% | -0.2% | 0.0% | -0.2% | -0.3% | -0.2% | |
| -15.0% | 45.9% | 0.4% | 44.3% | 13.3% | 15.6% | 22.6% | 26.3% | 24.3% | 27.4% | 29.3% | 23.3% | 18.4% | -0.1% | -9.5% | -9.7% | -142.9% | -18.8% | -10.3% | -151.9% | -46.4% | -63.9% | -83.5% | -61.4% | -71.6% | -5.7% | -24.1% | -37.1% | |
| 22.1% | 81.7% | 31.2% | 59.7% | 30.1% | 69.7% | 75.2% | 81.4% | 66.4% | 73.2% | 77.6% | 66.3% | 56.7% | 23.1% | 7.9% | 6.2% | 923.3% | 3.4% | 13.0% | -226.9% | -36.7% | -66.2% | -109.6% | -54.0% | -83.7% | 18.5% | -7.0% | -26.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.